How we choose topics
We prioritise questions that affect real life, safety, information access and communities poorly served by generic health content. Popularity never replaces importance.

Ask the Hub ↗Plain-English rules for useful, human T1D information—with receipts.
We prioritise questions that affect real life, safety, information access and communities poorly served by generic health content. Popularity never replaces importance.
Clinical claims should trace to current guidance, national health authorities, peer-reviewed literature or established diabetes organisations. Commercial marketing and unsourced blogs are not primary clinical evidence.
We explain ideas and possible considerations. We do not diagnose, prescribe, calculate insulin or interpret a visitor’s personal data.
A person’s story is authoritative about their experience, not universal clinical evidence. Story editing protects voice, consent and clarity.
Content carries an update date and review status. Substantive corrections are made transparently; broken or outdated information can be reported.
AI may assist drafting, structure or accessibility checks, but health claims require source checking and editorial responsibility. AI is never presented as a medical reviewer.
Only a genuine qualified reviewer may trigger a Medically reviewed label. Until then, health pages say Medical review pending.
Conflicts and commercial relationships must be disclosed. Funding never buys an editorial conclusion; sponsored work is clearly labelled.